Friday, July 17, 2026
India

Novo’s weight-loss drug Wegovy gets CDSCO approval for fatty liver disease

Novo’s weight-loss drug Wegovy gets CDSCO approval for fatty liver disease

The CDSCO has approved a new indication for Wegovy (semaglutide injection 2.4 mg) for treatment of noncirrhotic metabolic dysfunction associated steatohepatitis (MASH) in adults

Read the full story at Hindustan Times ↗

BriefNepal aggregates headlines. Full stories live on the original publisher’s site.

BriefNepal TravelExplore Nepal Like Never Before51 trekking guides · real 2026 costs in NPR · pilgrimage yatras · itineraries & free trip toolsStart planning your trip →

Related Articles

BriefNepal Travel

Plan Your Nepal Trip

All travel guides →

Not sure where to go? Take the 1-minute trek quiz →